Biotech

All Articles

' Medical intuition' led FDA experts to support Zevra's unusual condition med

.Zevra Therapies' rare health condition drug appears to become on the path to confirmation this autu...

Pfizer takes $230M struck after axing neglected DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics treatment breakdown has blown a $230 tho...

AC Immune sees 'site' prospective in Alzheimer's medication data

.After more than two decades of work on neurodegenerative ailments, Swiss biotech AC Immune system i...

GSK falls ph. 2 HPV injection over lack of best-in-class prospective

.GSK has ditched a stage 2 individual papillomavirus (HPV) vaccination from its pipeline after makin...

OS Therapies refiles $6M IPO to cash HER2 drug, preclinical ADCs

.OS Therapies will detail on the NYSE American inventory substitution today by means of a $6.4 thous...

ALX's waning CD47 action price delivers stock spiraling down

.ALX Oncology's stage 2 stomach cancer cells feedback price has diminished. After seeing its own CD4...

Ionis axes eye ailment coming from targets of Roche-partnered possibility after records dissatisfy

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has disappointed desires, triggering th...

Biogen's CEO stated no high-risk handle 2023. He prepares to be vibrant

.While Biogen's pharma peers are looking for late-stage properties with little bit of danger, CEO Ch...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Bio has actually been actually a biotech in search of a pipe after it junked its lead resour...

Biogen leaves Denali Alzheimer's collab

.Biogen has returned liberties to a very early Alzheimer's illness program to Denali Therapeutics, g...